Skip to content

A comparative study on the effects of herbal capsule of Melisa and Mefenamic acid on postpartum after pain

A comparative study on the effect of herbal capsules Melisa and Mefnamic acid on postpartum after pain on women that referred to Askarie hospitals of Isfahan in 2016

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201608023860N25
Enrollment
70
Registered
2016-12-28
Start date
2016-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After paine. postpartum care and examination

Interventions

Intervention 1: Intervention group: The samples were given a Melisa oral capsule containing 150 mg of dried extracts of Melisa ( produced in goldaro company ), two hour after delivery then every 6 hou
Treatment - Drugs
Intervention group: The samples were given a Melisa oral capsule containing 150 mg of dried extracts of Melisa ( produced in goldaro company ), two hour after delivery then every 6 hours for 24 hours.
control group:The samples were given a Mefenamic Acid oral capsule 250mg ,two hour after delivery then every 6 hours for 24 hours.

Sponsors

Vice chancellor for research of Shahid Beheshti University of Medical Sciences(SBUMS)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Iranian; speak the Persian language; lives with his wife; they had normal vaginal delivery; single pregnancy with healthy baby; Gestational age between 37 to 42 weeks; the mother have the ability to breast-feeding; The baby can be feeding; mother for research is satisfied; women who suffer from postpartum pain; severity of postpartum pain is moderate to severe (scored more than 4 degree based on Numerical scale and need to use narcotics); normal vaginal delivery without devices (Vacuum, forceps); the mother does not have cesarean section and abdominal surgery history; Not used of epidural or spinal anesthesia; Non-smoking and drug abuse; the mother does not have a chronic disease (Hypertension, diabetes, heart disease, infectious diseases); No have allergy to Melisa and other herbal drug. Exclusion criteria: the mother is suffering from serious complications after delivery (postpartum bleeding, temperature over 39 ° C, blood pressure higher than 140/90); continuation of breastfeeding to mother or baby is not possible causes; mother, for whatever reason are not willing to continue to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Seventry of pain. Timepoint: Before intervention - 2 hours after delivery - then every 6 hours for 24 hours. Method of measurement: Numerical Analogus Scale.

Secondary

MeasureTime frame
The Number of additinal analgesic. Timepoint: 2hours after delivery then every 6 hours numerical Analogus SCALE. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGity Ozgoli

School of Nursing and Midwifery of Shahid Beheshti University of Medical Sciences

gozgoli@yahoo.com+98 21 8820 2512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026